Business
Aeterna Zentaris to Announce Second Quarter 2011 Financial and Operating Results on August 10, 2011
QUEBEC CITY, Aug. 3, 2011 /CNW Telbec/ - Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX:AEZ) (the"...
About this update from Cosciens Biopharma Inc.
[{"type":"text","content":"\n\n\n\n\n\nQUEBEC CITY, Aug. 3, 2011 /CNW Telbec/ - Aeterna Zentaris Inc. (NASDAQ:\n AEZS) (TSX:AEZ) (the\"Company\") will announce its second quarter 2011\n financial and operating results on Wednesday, August 10, 2011. The\n Company will host a conference call and webcast to discuss these\n results later that same day at 3:30 p.m., Eastern Time.\n\n\nParticipants may access the live webcast via the Company's website at www.aezsinc.com in the \"Newsroom\" section, or by telephone using the following numbers:\n in Canada 514-807-8791 or 416-644-3425, outside Canada, 800-594-3790. A\n replay of the webcast will also be available on the Company's website\n for a period of 30 days.\n\n\nAbout Aeterna Zentaris Inc.\n\n\nAeterna Zentaris is a late-stage oncology drug development company\n currently investigating potential treatments for various cancers\n including colorectal, multiple myeloma, endometrial, ovarian, prostate\n and bladder cancer. The Company's innovative approach of \"personalized\n medicine\" means tailoring treatments to a patient's specific condition\n and to unmet medical needs. Aeterna Zentaris' deep pipeline is drawn\n from its proprietary discovery unit providing the Company with constant\n and long-term access to state-of-the-art therapeutic options. For more\n information please visit www.aezsinc.com.\n\n\n","length":1533,"tagName":"div"}]